Evidence map›Paper›PMID 38557587›Full record

ArticlePloS one2024

The right amygdala and migraine: Analyzing volume reduction and its relationship with symptom severity.

Shota Kosuge, Yuri Masaoka, Hideyo Kasai, Motoyasu Honma, Kouzou Murakami, Nobuyuki Yoshii, Keiko Watanabe, Takaaki Naito, Miku Kosuge, Misa Matsui and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Overlapping pathways of migraine and the endocannabinoid system: Potential therapeutic targets.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. The role of androgens in migraine pathophysiology.Neurobiology of pain (Cambridge, Mass.)
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Shota KosugeDepartment of Physiology, Showa University School of Medicine, Tokyo, Japan.
Yuri MasaokaDepartment of Physiology, Showa University School of Medicine, Tokyo, Japan.ORCID 0000-0002-0498-1825
Hideyo KasaiDepartment of Neurology, Showa University School of Medicine, Tokyo, Japan.
Motoyasu HonmaDepartment of Physiology, Showa University School of Medicine, Tokyo, Japan.
Kouzou MurakamiDepartment of Radiology, Showa University School of Medicine, Tokyo, Japan.ORCID 0000-0002-3484-9278
Nobuyuki YoshiiDepartment of Radiology, Showa University School of Medicine, Tokyo, Japan.
Keiko WatanabeDepartment of Physiology, Showa University School of Medicine, Tokyo, Japan.
Takaaki NaitoDepartment of Radiology, Showa University School of Medicine, Tokyo, Japan.
Miku KosugeDepartment of Physiology, Showa University School of Medicine, Tokyo, Japan.
Misa MatsuiDepartment of Physiology, Showa University School of Medicine, Tokyo, Japan.
Daiki ShojiDepartment of Physiology, Showa University School of Medicine, Tokyo, Japan.
Syunsuke SakakuraDepartment of Physiology, Showa University School of Medicine, Tokyo, Japan.
Hidetomo MurakamiDepartment of Neurology, Showa University School of Medicine, Tokyo, Japan.
Masahiko IzumizakiDepartment of Physiology, Showa University School of Medicine, Tokyo, Japan.
Showa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to explore the relationship between gray matter volume changes and various clinical parameters in patients with migraine, focusing on symptom severity, quality of life, and states of depression and anxiety. Using a case-control design, we examined 33 patients with migraine, with or without aura, and 27 age-matched healthy subjects. We used magnetic resonance imaging to assess the volumes of 140 bilateral brain regions. Clinical evaluations included the Migraine Disability Assessment, the Migraine Specific Quality of Life Questionnaire, the Center for Epidemiologic Studies Depression scale, Spielberger's State and Trait Anxiety scales, and the Japanese version of the Montreal Cognitive Assessment. We compared the scores of these measures between migraine patients and healthy controls to examine the interplay between brain structure and clinical symptoms. Significant volumetric differences were observed in the pallidum and amygdala between migraine patients and healthy individuals. The reduction in the right amygdala volume correlated significantly with migraine severity as measured by the Migraine Disability Assessment. Path analysis revealed a model where Migraine Disability Assessment scores were influenced by Migraine Specific Quality of Life Questionnaire outcomes, which were further affected by depression, anxiety, and a low right pallidum volume. Our findings suggest that the chronicity and severity of migraine headaches specifically affect the right amygdala. Our path model suggests a complex relationship whereby migraine disability is strongly influenced by quality of life, which is, in turn, affected by psychological states, such as anxiety and depression.

Indexed as

Migraine DisordersMigraine with AuraAnxietyBrainHumansMagnetic Resonance ImagingQuality of Life

Identifiers

PMID38557587
PMCPMC10984416
OpenAlexW4393392113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.